Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis
- 1 May 2002
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (7) , 1086-1087
- https://doi.org/10.1097/00002030-200205030-00022
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNAAIDS, 2001
- Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected AdultsA Randomized Equivalence TrialJAMA, 2001